Literature DB >> 2529742

Inhibition of autoimmune disease and the generation of suppressor cells by spirogermanium: a biological profile similar to total lymphoid irradiation.

A M Badger1, C K Mirabelli, B A Swift, M J DiMartino.   

Abstract

Oral administration of spirogermanium (Sg), inhibits the development of immune-mediated hindpaw inflammation in the rat model of adjuvant arthritis (AA) and DTH responses to PPD (30 mg/kg/day). A similar dosing protocol inhibits hindleg paralysis in experimental autoimmune encephalomyelitis (EAE). The spleens of these animals and those of normal rats contain radiation resistant (2000 R) non-specific suppressor cells (SC) which bear some similarity to those generated following total lymphoid irradiation (TLI). These cells do not appear to be mature T cells, they are partially adherent to plastic, sephadex G10 and nylon wool, insensitive to indomethacin and are enriched in a 1.07 g/ml fraction of a Percoll density gradient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529742     DOI: 10.1007/bf01972815

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  6 in total

1.  Antiarthritic and immunoregulatory activity of spirogermanium.

Authors:  M J DiMartino; J C Lee; A M Badger; K A Muirhead; C K Mirabelli; N Hanna
Journal:  J Pharmacol Exp Ther       Date:  1986-01       Impact factor: 4.030

2.  Preliminary study on the suppression of experimental autoimmune encephalomyelitis in the Lewis rat with spirogermanium.

Authors:  H J Sacks; V Braunstein; C F Brosnan
Journal:  J Neuropathol Exp Neurol       Date:  1987-05       Impact factor: 3.685

Review 3.  Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships.

Authors:  S Strober
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

4.  Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug.

Authors:  A M Badger; C K Mirabelli; M DiMartino
Journal:  Immunopharmacology       Date:  1985-12

5.  Suppressor cell induction by the anticancer drug spirogermanium.

Authors:  A M Badger; M J DiMartino; T C Schmitt; B A Swift; C K Mirabelli
Journal:  Int J Immunopharmacol       Date:  1987

6.  Immunomodulatory activity and non-specific suppressor cell generation by spirogermanium in murine and rat models of cell-mediated immunity.

Authors:  A M Badger; M J DiMartino; B A Swift; C K Mirabelli
Journal:  Immunopharmacology       Date:  1988 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.